Cargando…

The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development

Overweight and obesity are associated with type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease and cancer, but all fat is not equal, as storing excess lipid in subcutaneous white adipose tissue (SWAT) is more metabolically favorable than in visceral fat. Here, we uncover a cri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Wen-Yu, Jung, Su Myung, Tang, Yuefeng, Haley, John A., Li, Rui, Li, Huawei, Calejman, Camila Martinez, Sanchez-Gurmaches, Joan, Hung, Chien-Min, Luciano, Amelia K., DeMambro, Victoria, Wellen, Kathryn E., Rosen, Clifford J., Zhu, Lihua Julie, Guertin, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607535/
https://www.ncbi.nlm.nih.gov/pubmed/33027655
http://dx.doi.org/10.1016/j.celrep.2020.108223
_version_ 1783604664799854592
author Hsiao, Wen-Yu
Jung, Su Myung
Tang, Yuefeng
Haley, John A.
Li, Rui
Li, Huawei
Calejman, Camila Martinez
Sanchez-Gurmaches, Joan
Hung, Chien-Min
Luciano, Amelia K.
DeMambro, Victoria
Wellen, Kathryn E.
Rosen, Clifford J.
Zhu, Lihua Julie
Guertin, David A.
author_facet Hsiao, Wen-Yu
Jung, Su Myung
Tang, Yuefeng
Haley, John A.
Li, Rui
Li, Huawei
Calejman, Camila Martinez
Sanchez-Gurmaches, Joan
Hung, Chien-Min
Luciano, Amelia K.
DeMambro, Victoria
Wellen, Kathryn E.
Rosen, Clifford J.
Zhu, Lihua Julie
Guertin, David A.
author_sort Hsiao, Wen-Yu
collection PubMed
description Overweight and obesity are associated with type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease and cancer, but all fat is not equal, as storing excess lipid in subcutaneous white adipose tissue (SWAT) is more metabolically favorable than in visceral fat. Here, we uncover a critical role for mTORC2 in setting SWAT lipid handling capacity. We find that subcutaneous white preadipocytes differentiating without the essential mTORC2 subunit Rictor upregulate mature adipocyte markers but develop a striking lipid storage defect resulting in smaller adipocytes, reduced tissue size, lipid re-distribution to visceral and brown fat, and sex-distinct effects on systemic metabolic fitness. Mechanistically, mTORC2 promotes transcriptional upregulation of select lipid metabolism genes controlled by PPARγ and ChREBP, including genes that control lipid uptake, synthesis, and degradation pathways as well as Akt2, which encodes a major mTORC2 substrate and insulin effector. Further exploring this pathway may uncover new strategies to improve insulin sensitivity.
format Online
Article
Text
id pubmed-7607535
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-76075352020-11-03 The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development Hsiao, Wen-Yu Jung, Su Myung Tang, Yuefeng Haley, John A. Li, Rui Li, Huawei Calejman, Camila Martinez Sanchez-Gurmaches, Joan Hung, Chien-Min Luciano, Amelia K. DeMambro, Victoria Wellen, Kathryn E. Rosen, Clifford J. Zhu, Lihua Julie Guertin, David A. Cell Rep Article Overweight and obesity are associated with type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease and cancer, but all fat is not equal, as storing excess lipid in subcutaneous white adipose tissue (SWAT) is more metabolically favorable than in visceral fat. Here, we uncover a critical role for mTORC2 in setting SWAT lipid handling capacity. We find that subcutaneous white preadipocytes differentiating without the essential mTORC2 subunit Rictor upregulate mature adipocyte markers but develop a striking lipid storage defect resulting in smaller adipocytes, reduced tissue size, lipid re-distribution to visceral and brown fat, and sex-distinct effects on systemic metabolic fitness. Mechanistically, mTORC2 promotes transcriptional upregulation of select lipid metabolism genes controlled by PPARγ and ChREBP, including genes that control lipid uptake, synthesis, and degradation pathways as well as Akt2, which encodes a major mTORC2 substrate and insulin effector. Further exploring this pathway may uncover new strategies to improve insulin sensitivity. 2020-10-06 /pmc/articles/PMC7607535/ /pubmed/33027655 http://dx.doi.org/10.1016/j.celrep.2020.108223 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Hsiao, Wen-Yu
Jung, Su Myung
Tang, Yuefeng
Haley, John A.
Li, Rui
Li, Huawei
Calejman, Camila Martinez
Sanchez-Gurmaches, Joan
Hung, Chien-Min
Luciano, Amelia K.
DeMambro, Victoria
Wellen, Kathryn E.
Rosen, Clifford J.
Zhu, Lihua Julie
Guertin, David A.
The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development
title The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development
title_full The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development
title_fullStr The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development
title_full_unstemmed The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development
title_short The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development
title_sort lipid handling capacity of subcutaneous fat is programmed by mtorc2 during development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607535/
https://www.ncbi.nlm.nih.gov/pubmed/33027655
http://dx.doi.org/10.1016/j.celrep.2020.108223
work_keys_str_mv AT hsiaowenyu thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT jungsumyung thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT tangyuefeng thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT haleyjohna thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT lirui thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT lihuawei thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT calejmancamilamartinez thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT sanchezgurmachesjoan thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT hungchienmin thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT lucianoameliak thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT demambrovictoria thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT wellenkathryne thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT rosencliffordj thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT zhulihuajulie thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT guertindavida thelipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT hsiaowenyu lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT jungsumyung lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT tangyuefeng lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT haleyjohna lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT lirui lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT lihuawei lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT calejmancamilamartinez lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT sanchezgurmachesjoan lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT hungchienmin lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT lucianoameliak lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT demambrovictoria lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT wellenkathryne lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT rosencliffordj lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT zhulihuajulie lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment
AT guertindavida lipidhandlingcapacityofsubcutaneousfatisprogrammedbymtorc2duringdevelopment